Literature DB >> 29508663

Daptomycin and combination daptomycin-ceftaroline as salvage therapy for persistent methicillin-resistant Staphylococcus aureus bacteremia.

Nicolas Cortes-Penfield1, Nora T Oliver2,3, Andrew Hunter4, Maria Rodriguez-Barradas1,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29508663      PMCID： PMC6109258          DOI： 10.1080/23744235.2018.1448110

Source DB:  PubMed          Journal:  Infect Dis (Lond)        ISSN： 2374-4243


× No keyword cloud information.
  9 in total

Review 1.  Daptomycin non-susceptible, vancomycin-intermediate Staphylococcus aureus endocarditis treated with ceftaroline and daptomycin: case report and brief review of the literature.

Authors:  Sanjiv M Baxi; Dominic Chan; Vivek Jain
Journal:  Infection       Date:  2015-03-25       Impact factor: 3.553

2.  Evaluation of Ceftaroline Alone and in Combination against Biofilm-Producing Methicillin-Resistant Staphylococcus aureus with Reduced Susceptibility to Daptomycin and Vancomycin in an In Vitro Pharmacokinetic/Pharmacodynamic Model.

Authors:  Katie E Barber; Jordan R Smith; Cortney E Ireland; Blaise R Boles; Warren E Rose; Michael J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2015-05-18       Impact factor: 5.191

3.  A combination of ceftaroline and daptomycin has synergistic and bactericidal activity in vitro against daptomycin nonsusceptible methicillin-resistant Staphylococcus aureus (MRSA).

Authors:  Iffat Shafiq; Zackery P Bulman; Sarah L Spitznogle; Justin E Osorio; Irene S Reilly; Alan J Lesse; Ganapathi I Parameswaran; Kari A Mergenhagen; Brian T Tsuji
Journal:  Infect Dis (Lond)       Date:  2017-01-24

4.  Ceftaroline-Resistant, Daptomycin-Tolerant, and Heterogeneous Vancomycin-Intermediate Methicillin-Resistant Staphylococcus aureus Causing Infective Endocarditis.

Authors:  Masayuki Nigo; Lorena Diaz; Lina P Carvajal; Truc T Tran; Rafael Rios; Diana Panesso; Juan D Garavito; William R Miller; Audrey Wanger; George Weinstock; Jose M Munita; Cesar A Arias; Henry F Chambers
Journal:  Antimicrob Agents Chemother       Date:  2017-02-23       Impact factor: 5.191

Review 5.  Association between vancomycin minimum inhibitory concentration and mortality among patients with Staphylococcus aureus bloodstream infections: a systematic review and meta-analysis.

Authors:  Andre C Kalil; Trevor C Van Schooneveld; Paul D Fey; Mark E Rupp
Journal:  JAMA       Date:  2014-10-15       Impact factor: 56.272

6.  Ceftaroline increases membrane binding and enhances the activity of daptomycin against daptomycin-nonsusceptible vancomycin-intermediate Staphylococcus aureus in a pharmacokinetic/pharmacodynamic model.

Authors:  Brian J Werth; George Sakoulas; Warren E Rose; Joseph Pogliano; Ryan Tewhey; Michael J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2012-10-15       Impact factor: 5.191

7.  Combination of Vancomycin and β-Lactam Therapy for Methicillin-Resistant Staphylococcus aureus Bacteremia: A Pilot Multicenter Randomized Controlled Trial.

Authors:  Joshua S Davis; Archana Sud; Matthew V N O'Sullivan; James O Robinson; Patricia E Ferguson; Hong Foo; Sebastiaan J van Hal; Anna P Ralph; Benjamin P Howden; Paula M Binks; Adrienne Kirby; Steven Y C Tong; Steven Tong; Joshua Davis; Paula Binks; Suman Majumdar; Anna Ralph; Rob Baird; Claire Gordon; Cameron Jeremiah; Grace Leung; Anna Brischetto; Amy Crowe; Farshid Dakh; Kelly Whykes; Maria Kirkwood; Archana Sud; Mahesh Menon; Lucy Somerville; Shrada Subedi; Shirley Owen; Matthew O'Sullivan; Eunice Liu; Fei Zhou; Owen Robinson; Geoffrey Coombs; Patrician Ferguson; Anna Ralph; Eunice Liu; Simon Pollet; Sebastian Van Hal; Hong Foo; Sebastian Van Hal; Rebecca Davis
Journal:  Clin Infect Dis       Date:  2015-09-08       Impact factor: 9.079

8.  Observation of "seesaw effect" with vancomycin, teicoplanin, daptomycin and ceftaroline in 150 unique MRSA strains.

Authors:  Katie E Barber; Cortney E Ireland; Natalia Bukavyn; Michael J Rybak
Journal:  Infect Dis Ther       Date:  2014-01-18

9.  Predictors and clinical outcomes of persistent methicillin-resistant Staphylococcus aureus bacteremia: a prospective observational study.

Authors:  Hea Sung Ok; Hyoun Soo Lee; Man Je Park; Ki Hoon Kim; Byeong Ki Kim; Yu Mi Wi; June Myung Kim
Journal:  Korean J Intern Med       Date:  2013-10-29       Impact factor: 2.884
  9 in total
  6 in total

Review 1.  The Emerging Role of β-Lactams in the Treatment of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.

Authors:  Kyle C Molina; Taylor Morrisette; Matthew A Miller; Vanthida Huang; Douglas N Fish
Journal:  Antimicrob Agents Chemother       Date:  2020-06-23       Impact factor: 5.191

Review 2.  Mini Review on Antimicrobial Peptides, Sources, Mechanism and Recent Applications.

Authors:  Jaspreet Kaur Boparai; Pushpender Kumar Sharma
Journal:  Protein Pept Lett       Date:  2020       Impact factor: 1.890

3.  Adjunctive ceftaroline in combination with daptomycin or vancomycin for complicated methicillin-resistant Staphylococcus aureus bacteremia after monotherapy failure.

Authors:  Joseph Patrik Hornak; Seher Anjum; David Reynoso
Journal:  Ther Adv Infect Dis       Date:  2019-11-07

Review 4.  Comparing the Outcomes of Ceftaroline plus Vancomycin or Daptomycin Combination Therapy versus Vancomycin or Daptomycin Monotherapy in Adults with Methicillin-Resistant Staphylococcus aureus Bacteremia-A Meta-Analysis.

Authors:  Chienhsiu Huang; Ihung Chen; Lichen Lin
Journal:  Antibiotics (Basel)       Date:  2022-08-15

5.  Monotherapy with Vancomycin or Daptomycin versus Combination Therapy with β-Lactams in the Treatment of Methicillin-Resistant Staphylococcus Aureus Bloodstream Infections: A Retrospective Cohort Analysis.

Authors:  Sara Alosaimy; Noor L Sabagha; Abdalhamid M Lagnf; Evan J Zasowski; Taylor Morrisette; Sarah C J Jorgensen; Trang D Trinh; Ryan P Mynatt; Michael J Rybak
Journal:  Infect Dis Ther       Date:  2020-04-04

6.  Use of Ceftaroline in Hospitalized Patients with and without COVID-19: A Descriptive Cross-Sectional Study.

Authors:  Daniele Roberto Giacobbe; Chiara Russo; Veronica Martini; Silvia Dettori; Federica Briano; Michele Mirabella; Federica Portunato; Chiara Dentone; Sara Mora; Mauro Giacomini; Marco Berruti; Matteo Bassetti
Journal:  Antibiotics (Basel)       Date:  2021-06-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.